Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electrodiagnosis | 4 | 2020 | 12 | 2.040 |
Why?
|
| Neural Conduction | 7 | 2021 | 34 | 1.700 |
Why?
|
| Neurology | 3 | 2023 | 40 | 1.330 |
Why?
|
| Electromyography | 4 | 2022 | 131 | 1.310 |
Why?
|
| Ultrasonography | 2 | 2020 | 437 | 1.230 |
Why?
|
| Societies, Medical | 6 | 2023 | 177 | 1.170 |
Why?
|
| Neurophysiology | 5 | 2024 | 9 | 0.950 |
Why?
|
| Polyneuropathies | 3 | 2017 | 6 | 0.920 |
Why?
|
| Neuromuscular Diseases | 2 | 2022 | 30 | 0.910 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2019 | 57 | 0.820 |
Why?
|
| Axons | 1 | 2021 | 45 | 0.780 |
Why?
|
| Dictionaries as Topic | 1 | 2020 | 1 | 0.720 |
Why?
|
| Terminology as Topic | 1 | 2020 | 62 | 0.690 |
Why?
|
| Amyloid Neuropathies, Familial | 4 | 2020 | 5 | 0.570 |
Why?
|
| Oligonucleotides | 3 | 2020 | 81 | 0.490 |
Why?
|
| Disease Progression | 3 | 2020 | 831 | 0.470 |
Why?
|
| Health Care Costs | 1 | 2014 | 170 | 0.430 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 89 | 0.430 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 286 | 0.410 |
Why?
|
| Amyloidosis, Familial | 1 | 2011 | 2 | 0.390 |
Why?
|
| Neurologic Examination | 1 | 2011 | 77 | 0.380 |
Why?
|
| Peripheral Nerves | 2 | 2007 | 49 | 0.370 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2020 | 28 | 0.360 |
Why?
|
| Amyloid Neuropathies | 2 | 2007 | 2 | 0.360 |
Why?
|
| Diabetic Neuropathies | 2 | 2007 | 49 | 0.350 |
Why?
|
| Humans | 33 | 2024 | 50208 | 0.350 |
Why?
|
| Motor Neurons | 1 | 2007 | 39 | 0.300 |
Why?
|
| Neurons, Afferent | 1 | 2007 | 30 | 0.300 |
Why?
|
| Molecular Biology | 1 | 2007 | 25 | 0.300 |
Why?
|
| Myotonic Dystrophy | 2 | 2022 | 13 | 0.290 |
Why?
|
| Larynx | 2 | 2020 | 30 | 0.290 |
Why?
|
| Electrocardiography | 3 | 2016 | 262 | 0.270 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 765 | 0.250 |
Why?
|
| Accessory Nerve Diseases | 1 | 2003 | 1 | 0.230 |
Why?
|
| Tongue Neoplasms | 1 | 2003 | 11 | 0.230 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 36 | 0.230 |
Why?
|
| United States | 7 | 2024 | 4874 | 0.220 |
Why?
|
| Testicular Neoplasms | 1 | 2024 | 64 | 0.220 |
Why?
|
| Neuralgia | 1 | 2024 | 63 | 0.210 |
Why?
|
| Carcinoma | 1 | 2003 | 139 | 0.210 |
Why?
|
| Demyelinating Diseases | 1 | 2002 | 7 | 0.200 |
Why?
|
| Blood Component Removal | 1 | 2002 | 10 | 0.200 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2002 | 10 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 449 | 0.200 |
Why?
|
| Neuromuscular Junction | 1 | 2021 | 9 | 0.200 |
Why?
|
| Virus Diseases | 1 | 2022 | 40 | 0.200 |
Why?
|
| Myelin Sheath | 1 | 2021 | 28 | 0.200 |
Why?
|
| Hypoglycemic Agents | 1 | 2003 | 168 | 0.190 |
Why?
|
| Hypersensitivity | 1 | 2022 | 77 | 0.190 |
Why?
|
| Laryngoplasty | 1 | 2020 | 7 | 0.190 |
Why?
|
| Insulin | 1 | 2003 | 456 | 0.180 |
Why?
|
| Laryngectomy | 1 | 2020 | 28 | 0.180 |
Why?
|
| Prealbumin | 3 | 2007 | 21 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 201 | 0.180 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 34 | 0.180 |
Why?
|
| Muscle Weakness | 1 | 2020 | 44 | 0.180 |
Why?
|
| Tibial Nerve | 2 | 2011 | 6 | 0.180 |
Why?
|
| Tissue Engineering | 1 | 2020 | 65 | 0.180 |
Why?
|
| Health Personnel | 1 | 2023 | 254 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2020 | 88 | 0.170 |
Why?
|
| Action Potentials | 2 | 2011 | 132 | 0.170 |
Why?
|
| Upper Extremity | 1 | 2019 | 44 | 0.160 |
Why?
|
| Asthma | 1 | 2022 | 280 | 0.160 |
Why?
|
| Quality of Life | 2 | 2024 | 839 | 0.160 |
Why?
|
| Middle Aged | 10 | 2024 | 12206 | 0.150 |
Why?
|
| Male | 13 | 2024 | 25399 | 0.150 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2017 | 5 | 0.150 |
Why?
|
| Respirovirus Infections | 1 | 2017 | 6 | 0.150 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2017 | 5 | 0.150 |
Why?
|
| Physicians | 2 | 2023 | 230 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2016 | 19 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 119 | 0.140 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 45 | 0.130 |
Why?
|
| Orphan Drug Production | 1 | 2015 | 1 | 0.130 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2015 | 1 | 0.130 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 3 | 0.130 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 16 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 170 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1186 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 951 | 0.110 |
Why?
|
| Adult | 7 | 2024 | 13324 | 0.110 |
Why?
|
| Skin | 1 | 2016 | 415 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 21 | 0.110 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 7 | 0.100 |
Why?
|
| Female | 10 | 2020 | 26635 | 0.100 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 40 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2011 | 24 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 55 | 0.090 |
Why?
|
| Sural Nerve | 2 | 2007 | 8 | 0.090 |
Why?
|
| Synkinesis | 1 | 2009 | 2 | 0.090 |
Why?
|
| Phenol | 1 | 2009 | 6 | 0.090 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2009 | 7 | 0.090 |
Why?
|
| Sclerosing Solutions | 1 | 2009 | 15 | 0.090 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 31 | 0.090 |
Why?
|
| Vincristine | 1 | 2009 | 88 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 905 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2011 | 251 | 0.080 |
Why?
|
| West Nile Fever | 1 | 2008 | 3 | 0.080 |
Why?
|
| Aged | 4 | 2020 | 9405 | 0.080 |
Why?
|
| Paralysis | 1 | 2008 | 9 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 2190 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 2008 | 37 | 0.080 |
Why?
|
| Echocardiography | 1 | 2011 | 375 | 0.080 |
Why?
|
| Vibration | 1 | 2007 | 13 | 0.080 |
Why?
|
| Peroneal Nerve | 1 | 2007 | 6 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 57 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2007 | 12 | 0.080 |
Why?
|
| Gelsolin | 1 | 2007 | 2 | 0.080 |
Why?
|
| Apolipoprotein A-I | 1 | 2007 | 7 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 93 | 0.070 |
Why?
|
| Heart Rate | 2 | 2020 | 298 | 0.070 |
Why?
|
| Reaction Time | 1 | 2007 | 216 | 0.070 |
Why?
|
| Amyloid | 2 | 2003 | 28 | 0.070 |
Why?
|
| Child | 4 | 2022 | 6851 | 0.070 |
Why?
|
| Decompression, Surgical | 1 | 2006 | 51 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 863 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2003 | 213 | 0.060 |
Why?
|
| Societies | 1 | 2024 | 7 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 466 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2003 | 24 | 0.060 |
Why?
|
| Survivors | 1 | 2024 | 125 | 0.050 |
Why?
|
| Certification | 1 | 2023 | 49 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2023 | 68 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1554 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 5155 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 2954 | 0.050 |
Why?
|
| Respiratory Sounds | 1 | 2022 | 48 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2022 | 119 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1294 | 0.050 |
Why?
|
| Laryngeal Cartilages | 1 | 2020 | 1 | 0.050 |
Why?
|
| Motor Endplate | 1 | 2020 | 4 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2020 | 16 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2020 | 13 | 0.050 |
Why?
|
| Phonation | 1 | 2020 | 13 | 0.050 |
Why?
|
| Myoblasts | 1 | 2020 | 18 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 61 | 0.050 |
Why?
|
| Reflex | 1 | 2020 | 31 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2020 | 33 | 0.050 |
Why?
|
| Deglutition | 1 | 2020 | 42 | 0.040 |
Why?
|
| Pain | 1 | 2003 | 381 | 0.040 |
Why?
|
| Swine | 1 | 2020 | 396 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2020 | 187 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 688 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 697 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 484 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2020 | 650 | 0.040 |
Why?
|
| International Cooperation | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1581 | 0.040 |
Why?
|
| Stellate Ganglion | 1 | 2016 | 3 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2017 | 87 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2017 | 79 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Cross Infection | 1 | 2017 | 93 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 76 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 310 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 1108 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1458 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1126 | 0.030 |
Why?
|
| Stroboscopy | 1 | 2012 | 4 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1422 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 129 | 0.030 |
Why?
|
| Otolaryngology | 1 | 2012 | 56 | 0.030 |
Why?
|
| H-Reflex | 1 | 2011 | 28 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2011 | 118 | 0.020 |
Why?
|
| Adolescent | 1 | 2003 | 6390 | 0.020 |
Why?
|
| Animals | 2 | 2020 | 13246 | 0.020 |
Why?
|
| Laryngeal Muscles | 1 | 2009 | 2 | 0.020 |
Why?
|
| Vocal Cords | 1 | 2009 | 8 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 21 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 3154 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2009 | 58 | 0.020 |
Why?
|
| Poliomyelitis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Tachycardia | 1 | 2008 | 29 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2008 | 177 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 149 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 6134 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 247 | 0.020 |
Why?
|
| Alanine | 1 | 2003 | 42 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 50 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 103 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 37 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3299 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 1954 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 601 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2002 | 66 | 0.010 |
Why?
|
| Pedigree | 1 | 2002 | 125 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 84 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 1541 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 644 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 438 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 586 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3629 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 541 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 2922 | 0.010 |
Why?
|